Epidermal growth factor receptor inhibitor protects against abdominal aortic aneurysm in a mouse model. (Q53655930)

16 May 2018

title

Epidermal growth factor receptor inhibitor protects against abdominal aortic aneurysm in a mouse model. (English)

1 reference

16 May 2018

abdominal aortic aneurysm

main subject

1 reference

Takashi Obama

1

1 reference

16 May 2018

Toshiyuki Tsuji

2

1 reference

16 May 2018

Tomonori Kobayashi

3

1 reference

16 May 2018

Yamato Fukuda

4

1 reference

16 May 2018

Takehiko Takayanagi

5

1 reference

16 May 2018

Yoshinori Taro

6

1 reference

16 May 2018

Tatsuo Kawai

7

1 reference

16 May 2018

Steven J Forrester

8

1 reference

16 May 2018

Katherine J Elliott

9

1 reference

16 May 2018

Eric Choi

10

1 reference

16 May 2018

Alan Daugherty

11

1 reference

16 May 2018

Victor Rizzo

12

1 reference

16 May 2018

Satoru Eguchi

13

1 reference

16 May 2018

language of work or name

English

0 references

publication date

1 May 2015

1 reference

16 May 2018

published in

Clinical Science

1 reference

16 May 2018

volume

128

1 reference

16 May 2018

issue

9

1 reference

16 May 2018

page(s)

559-565

1 reference

16 May 2018

Involvement of the renin-angiotensin system in abdominal and thoracic aortic aneurysms.

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

ADAM17 silencing by adenovirus encoding miRNA-embedded siRNA revealed essential signal transduction by angiotensin II in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

Tumor necrosis factor-α converting enzyme is a key mediator of abdominal aortic aneurysm development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

Caveolin-1 negatively regulates a metalloprotease-dependent epidermal growth factor receptor transactivation by angiotensin II

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

Caveolin 1 is critical for abdominal aortic aneurysm formation induced by angiotensin II and inhibition of lysyl oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

Transcriptional profiling and network analysis of the murine angiotensin II-induced abdominal aortic aneurysm

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

Ehlers-Danlos syndrome has varied molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

Pharmacologically induced thoracic and abdominal aortic aneurysms in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

The role of lysyl oxidase family members in the stabilization of abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

21 January 2018

Erlotinib hydrochloride

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

Endothelial nitric oxide synthase inhibits G12/13 and rho-kinase activated by the angiotensin II type-1 receptor: implication in vascular migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

EGFR signaling promotes TGFβ-dependent renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

Vascular induction of a disintegrin and metalloprotease 17 by angiotensin II through hypoxia inducible factor 1α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

Neutrophil-derived matrix metalloproteinase 9 triggers acute aortic dissection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

Role of cAMP response element binding protein in cardiovascular remodeling: good, bad, or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

Overexpression of catalase in vascular smooth muscle cells prevents the formation of abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

Conundrum of angiotensin II and TGF-β interactions in aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140696

21 January 2018

Identifiers

DOI

10.1042/CS20140696

1 reference

16 May 2018

PubMed ID

25531554

1 reference

16 May 2018